Clinical Trials for Everolimus (RAD001)

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentECOGBRES1207
10/31/2013
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with High-Risk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer. e3 Breast Cancer Study- evaluating everolimus with endocrine therapy.
TreatmentVICCBRE1304
06/04/2013
A Phase II Study Evaluating the Efficacy and Tolerability of Everolimus (RAD001) in Combination with Trastuzumab and Vinorelbine in the Treatment of Progressive HER2-Positive Breast Cancer Brain Metastases

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.